Slideset
View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Mansoor Raza Mirza, MD, and Ana Oaknin, MD, PhD, discuss the implications of recent advances in the use of immunotherapy for the treatment of patients with endometrial cancer.
Presenters:
Ana Oaknin, MD, PhD
Head of Gynecologic Tumors Unit
Medical Oncology Department
Vall d´Hebron University Hospital
Barcelona, Spain
Mansoor Raza Mirza, MD
Chief Oncologist
Department of Oncology,
Rigshopitalet – Copenhagen University Hospital
Copenhagen, Denmark
Expert slides on biologic principles, indications, and clinical biomarkers for immune checkpoint inhibitors, from Clinical Care Options (CCO)
Sandip P. Patel, MD
Released: April 16, 2021
Expert slides on multidisciplinary management of immune-related adverse events associated with checkpoint inhibitors, from Clinical Care Options (CCO)
Marianne Davies, DNP, CNS, ACNP-BC, AOCNP
Released: April 16, 2021
Clinical Care Options (CCO) on-demand video featuring expert perspectives on using cytokine therapy for melanoma
Ahmad Tarhini, MD, PhD
George Ebanks, RN, BSN, OCN
Jennifer Swank, PharmD, BCOP
Physicians:
maximum of 1.0 AMA PRA Category 1 Credit™
Registered Nurses:
1.0 Nursing contact hour
Pharmacists:
1.0 contact hour (0.1 CEUs)
Released: April 8, 2021
Expired:
April 7, 2022
Downloadable slideset updated with highlights of key gynecologic oncology studies presented at conferences throughout 2021, from Clinical Care Options (CCO)
Jubilee Brown, MD
Ursula Matulonis, MD
Released: April 8, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.